Erratum for: PTHrP-mediated hypercalcemia: Causes and survival in 138 patients (Journal of Clinical Endocrinology and Metabolism (2015) 100:5 (2024-2029) DOI: 10.1210/jc.2014-4250);PTHrP-mediated hypercalcemia: Causes and survival in 138 patients

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 5, 2015, Pages 2024-2029

  Donovan, Peter J ^a,b,d   Achong, Naomi ^b   Griffin, Katherine ^c   Galligan, John ^d   Pretorius, Carel J ^b   McLeod, Donald S A ^a,b,e  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c GOLD COAST UNIVERSITY HOSPITAL   (Australia)

^d Pathology Queensland ^*  (Australia)

^e QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE RELATED PROTEIN; CALCIUM;

ADENOCARCINOMA; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUSTRALIA; BENIGN TUMOR; CASE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DUODENUM CARCINOMA; FEMALE; HEMANGIOENDOTHELIOMA; HEMATOLOGIC MALIGNANCY; HUMAN; HYPERCALCEMIA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL DOCUMENTATION; MERKEL CELL TUMOR; MIDDLE AGED; MYXOSARCOMA; OVERALL SURVIVAL; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; PROGNOSIS; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; SOLID TUMOR; SQUAMOUS CELL LUNG CARCINOMA; BLOOD; COMPLICATION; MORTALITY; NEOPLASM; SURVIVAL RATE;

AGED; CALCIUM; FEMALE; HUMANS; HYPERCALCEMIA; MALE; MIDDLE AGED; NEOPLASMS; PARATHYROID HORMONE-RELATED PROTEIN; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84929378099     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2019-00525     Document Type: Erratum

References (17)

1. Case Records of the Massachusetts General Hospital: case 27461. N Engl J Med 1941;225:789-791.
2. Burtis WJ, Wu T, Bunch C, et al. Identification of a novel 17,000- dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem. 1987;262:7151-7156.
3. th ed. Philadelphia. PA: Saunders/Elsevier; 2008.
4. Hashimoto H, Azuma Y, Kawasaki M, et al. Parathyroid hormone-related protein induces cachectic syndromes without directly modulating the expression of hypothalamic feeding-regulating peptides. Clin Cancer Res. 2007;13:292-298.
5. Jacobs TP, Bilezikian JP. Clinical review: rare causes of hypercalcemia. J Clin Endocrinol Metab. 2005;90:6316-6322.
6. Savvari P, Peitsidis P, Alevizaki M, Dimopoulos MA, Antsaklis A, Papadimitriou CA. Paraneoplastic humorally mediated hypercalcemia induced by parathyroid hormone-related protein in gynecologic malignancies: a systematic review. Onkologie. 2009;32:517-523.
7. Sato K. Hypercalcemia during pregnancy, puerperium, and lactation: review and a case report of hypercalcemic crisis after delivery due to excessive production of PTH-related protein (PTHrP) without malignancy (humoral hypercalcemia of pregnancy). Endocr J. 2008;55:959-966.
8. Stewart AF. Clinical practice. Hypercalcemia associated with cancer. N Engl J Med. 2005;352:373-379.
9. Ralston SH, Gallacher SJ, Patel U, Campbell J, Boyle IT. Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med. 1990;112:499-504.
10. Donovan PJ, Sundac L, Pretorius CJ, d'Emden MC, McLeod DS. Calcitriol-mediated hypercalcemia: causes and course in 101 patients. J Clin Endocrinol Metab. 2013;98:4023-4029.
11. Fraser WD, Robinson J, Lawton R, et al. Clinical and laboratory studies of a new immunoradiometric assay of parathyroid hormonerelated protein. Clin Chem. 1993;39:414-419.
12. Ikeda K, Ohno H, Hane M, et al. Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemia/lymphoma and B-cell lymphoma. J Clin Endocrinol Metab. 1994;79:1322-1327.
13. Lum G. Falsely elevated parathyroid hormone-related protein (PTH-RP) in a patient with hypercalcemia and renal failure. Lab Med. 2011;42:726-728.
14. Zhang SJ, Hu Y, Cao J, et al. Analysis on survival and prognostic factors for cancer patients with malignancy-associated hypercalcemia. Asian Pac J Cancer Prev. 2014;14:6715-6719.
15. Le Tinier F, Vanhuyse M, Penel N, Dewas S, El-Bedoui S, Adenis A. Cancer-associated hypercalcaemia in squamous-cell malignancies: a survival and prognostic factor analysis. Int J Oral Maxillofac Surg. 2011;40:938-942.
16. Penel N, Berthon C, Everard F, et al. Prognosis of hypercalcemia in aerodigestive tract cancers: study of 136 recent cases. Oral Oncol. 2005;41:884-889.
17. Mundy GR, Edwards JR. PTH-related peptide (PTHrP) in hypercalcemia. J Am Soc Nephrol. 2008;19:672-675.